Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2025-12-30 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-12-30 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing an upsize of a private placement (a capital raising activity). It details the gross proceeds, the number of shares to be issued, the intended use of proceeds, and the expected closing date. This fits the definition of a Capital/Financing Update (CAP) as it relates to fundraising and capital structure changes.
2025-12-24 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the closing of a registered direct offering of common shares and the intent to complete a subsequent private placement. This falls under the category of capital raising and financing activities. It is not a report itself, but an announcement of a financial transaction.
2025-12-23 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing a capital raise (registered direct offering and private placement) by Profound Medical Corp. It details the pricing, the number of shares, the use of proceeds, and the involvement of a placement agent. This falls squarely under the definition of a Capital/Financing Update (CAP), as it describes the company's fundraising activities and changes to its capital structure.
2025-12-19 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a press release issued by Profound Medical Corp. announcing that a researcher received an award for a presentation on the company's CAPTAIN clinical trial at the RSNA Annual Meeting. It provides details about the trial results and the company's technology, but it does not constitute a formal financial report, audit, or regulatory filing. As it is a general corporate announcement regarding company activities and research milestones, it falls under the 'Regulatory Filings' (RNS) category as the best fit for miscellaneous corporate news.
2025-12-04 English
News release - English.pdf
Regulatory Filings
2025-11-28 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.